These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2846765)

  • 1. Single amino acid change at the cleavage site of the fusion protein is responsible for both enhanced chymotrypsin sensitivity and trypsin resistance of a Sendai virus mutant, TR-5.
    Itoh M; Homma M
    J Gen Virol; 1988 Nov; 69 ( Pt 11)():2907-11. PubMed ID: 2846765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single amino acid substitution of Sendai virus at the cleavage site of the fusion protein confers trypsin resistance.
    Itoh M; Shibuta H; Homma M
    J Gen Virol; 1987 Nov; 68 ( Pt 11)():2939-44. PubMed ID: 2824671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pneumopathogenicity in mice of a Sendai virus mutant, TSrev-58, is accompanied by in vitro activation with trypsin.
    Mochizuki Y; Tashiro M; Homma M
    J Virol; 1988 Aug; 62(8):3040-2. PubMed ID: 2839720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pneumopathogenicity of a Sendai virus protease-activation mutant, TCs, which is sensitive to trypsin and chymotrypsin.
    Itoh M; Ming TD; Hayashi T; Mochizuki Y; Homma M
    J Virol; 1990 Nov; 64(11):5660-4. PubMed ID: 2170692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in specific cleavability of the Sendai virus fusion protein: implications for pathogenicity in mice.
    Tashiro M; Seto JT; Choosakul S; Hegemann H; Klenk HD; Rott R
    J Gen Virol; 1992 Jun; 73 ( Pt 6)():1575-9. PubMed ID: 1339465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pneumotropic revertants derived from a pantropic mutant, F1-R, of Sendai virus.
    Tashiro M; James I; Karri S; Wahn K; Tobita K; Klenk HD; Rott R; Seto JT
    Virology; 1991 Sep; 184(1):227-34. PubMed ID: 1651590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protease activation mutants of Sendai virus: sequence analysis of the mRNA of the fusion protein (F) gene and direct identification of the cleavage-activation site.
    Hsu MC; Scheid A; Choppin PW
    Virology; 1987 Jan; 156(1):84-90. PubMed ID: 3027971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Budding site of Sendai virus in polarized epithelial cells is one of the determinants for tropism and pathogenicity in mice.
    Tashiro M; Seto JT; Choosakul S; Yamakawa M; Klenk HD; Rott R
    Virology; 1992 Apr; 187(2):413-22. PubMed ID: 1312267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single amino acid mutation at position 170 of human parainfluenza virus type 1 fusion glycoprotein induces obvious syncytium formation and caspase-3-dependent cell death.
    Takaguchi M; Takahashi T; Hosokawa C; Ueyama H; Fukushima K; Hayakawa T; Itoh K; Ikeda K; Suzuki T
    J Biochem; 2011 Feb; 149(2):191-202. PubMed ID: 21186250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutations in Sendai virus variant F1-R that correlate with plaque formation in the absence of trypsin.
    Hou X; Suquilanda E; Zeledon A; Kacsinta A; Moore A; Seto J; McQueen N
    Med Microbiol Immunol; 2005 May; 194(3):129-36. PubMed ID: 15834752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Attempts to convert chymotrypsin to trypsin.
    Venekei I; Szilágyi L; Gráf L; Rutter WJ
    FEBS Lett; 1996 Mar; 383(1-2):143-7. PubMed ID: 8612781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ala226 to Gly and Ser189 to Asp mutations convert rat chymotrypsin B to a trypsin-like protease.
    Jelinek B; Antal J; Venekei I; Gráf L
    Protein Eng Des Sel; 2004 Feb; 17(2):127-31. PubMed ID: 15047908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlled proteolytic digestion of the M-protein of Sendai virus: the isolation of a fragment of 30000 molecular weight.
    Hewitt JA; Allen G
    J Gen Virol; 1978 May; 39(2):311-9. PubMed ID: 206657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trypsin: a case study in the structural determinants of enzyme specificity.
    Hedstrom L
    Biol Chem; 1996; 377(7-8):465-70. PubMed ID: 8922280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attempts to convert chymotrypsin to trypsin.
    Venekei I; Szilágyi L; Gráf L; Rutter WJ
    FEBS Lett; 1996 Jan; 379(2):143-7. PubMed ID: 8635580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A protease activation mutant, MVCES1, as a safe and potent live vaccine derived from currently prevailing Sendai virus.
    Wang XL; Itoh M; Hotta H; Homma M
    J Virol; 1994 May; 68(5):3369-73. PubMed ID: 8151795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Converting trypsin to chymotrypsin: structural determinants of S1' specificity.
    Kurth T; Ullmann D; Jakubke HD; Hedstrom L
    Biochemistry; 1997 Aug; 36(33):10098-104. PubMed ID: 9254605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trypsin-resistant protease activation mutants of an influenza virus.
    Orlich M; Linder D; Rott R
    J Gen Virol; 1995 Mar; 76 ( Pt 3)():625-33. PubMed ID: 7897352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of trypsin I as a candidate for influenza A virus and Sendai virus envelope glycoprotein processing protease in rat brain.
    Le TQ; Kawachi M; Yamada H; Shiota M; Okumura Y; Kido H
    Biol Chem; 2006 Apr; 387(4):467-75. PubMed ID: 16606346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular processing of the human respiratory syncytial virus fusion glycoprotein: amino acid substitutions affecting folding, transport and cleavage.
    Anderson K; Stott EJ; Wertz GW
    J Gen Virol; 1992 May; 73 ( Pt 5)():1177-88. PubMed ID: 1375280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.